Results 51 to 60 of about 1,854,472 (300)

On Inverse Probability Weighting for Nonmonotone Missing at Random Data [PDF]

open access: yesJournal of the American Statistical Association, 2017
The development of coherent missing data models to account for nonmonotone missing at random (MAR) data by inverse probability weighting (IPW) remains to date largely unresolved. As a consequence, IPW has essentially been restricted for use only in monotone MAR settings.
Sun, BaoLuo, Tchetgen, Eric J. Tchetgen
openaire   +3 more sources

IPWLOGIT: Stata module to fit marginal logistic regression by inverse probability weighting

open access: yes, 2023
IPWLOGIT fits marginal logistic regression of a binary dependent variable on a treatment variable, possibly adjusting for control variables by inverse probability weighting (IPW).
Jann, Ben
core  

Modeling Secondary Phenotypes Conditional on Genotypes in Case–Control Studies

open access: yesStats, 2022
Traditional case–control genetic association studies examine relationships between case–control status and one or more covariates. It is becoming increasingly common to study secondary phenotypes and their association with the original covariates.
Naomi C. Brownstein   +5 more
doaj   +1 more source

Constructing Inverse Probability Weights for Marginal Structural Models [PDF]

open access: yesAmerican Journal of Epidemiology, 2008
The method of inverse probability weighting (henceforth, weighting) can be used to adjust for measured confounding and selection bias under the four assumptions of consistency, exchangeability, positivity, and no misspecification of the model used to estimate weights.
Stephen R, Cole, Miguel A, Hernán
openaire   +2 more sources

Standardized differences to identify imbalances between treatment groups before and after imputing and inverse-probability-of-treatment-weighting.

open access: yes, 2016
Standardized differences to identify imbalances between treatment groups before and after imputing and inverse-probability-of-treatment-weighting.
Anna Suling (759811)   +9 more
core   +1 more source

sj-zip-1-smm-10.1177_09622802231199335 - Supplemental material for Variable selection using inverse probability of censoring weighting

open access: yes, 2023
Supplemental material, sj-zip-1-smm-10.1177_09622802231199335 for Variable selection using inverse probability of censoring weighting by Masahiro Kojima in Statistical Methods in Medical ...
Masahiro Kojima (3719785)
core   +1 more source

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Relative risk and adjusted SARs of COVID-19 secondary case using an inverse probability weighting in Pakistani household contacts.

open access: yes, 2022
Relative risk and adjusted SARs of COVID-19 secondary case using an inverse probability weighting in Pakistani household contacts.
Asghar Khan (9377860)   +18 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study

open access: yesTrials, 2019
Background Randomized trials are considered the gold standard for making inferences about the causal effects of treatments. However, when protocol deviations occur, the baseline randomization of the trial is no longer sufficient to ensure unbiased ...
Jessica G. Young   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy